SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,895,528 | +11.6% | 10,115,000 | 0.0% | 0.09% | +15.6% |
| Q3 2022 | $16,926,000 | -36.5% | 10,115,000 | -52.1% | 0.08% | -33.0% |
| Q2 2022 | $26,667,000 | -3.9% | 21,131,000 | 0.0% | 0.12% | +10.6% |
| Q1 2022 | $27,741,000 | -10.0% | 21,131,000 | 0.0% | 0.10% | -9.6% |
| Q4 2021 | $30,817,000 | -12.0% | 21,131,000 | -10.6% | 0.12% | -24.8% |
| Q3 2021 | $35,035,000 | +4.9% | 23,631,000 | -6.0% | 0.15% | 0.0% |
| Q2 2021 | $33,392,000 | +1.9% | 25,131,000 | 0.0% | 0.15% | -14.5% |
| Q1 2021 | $32,780,000 | -46.7% | 25,131,000 | 0.0% | 0.18% | -49.9% |
| Q4 2020 | $61,472,000 | +18.3% | 25,131,000 | +0.3% | 0.36% | +6.9% |
| Q3 2020 | $51,955,000 | -10.2% | 25,051,000 | -0.3% | 0.33% | -18.3% |
| Q2 2020 | $57,829,000 | +42.5% | 25,136,000 | -5.0% | 0.41% | +28.6% |
| Q1 2020 | $40,570,000 | -27.2% | 26,471,000 | -7.0% | 0.32% | +15.2% |
| Q4 2019 | $55,765,000 | +48.1% | 28,471,000 | 0.0% | 0.28% | +34.6% |
| Q3 2019 | $37,660,000 | -40.8% | 28,471,000 | 0.0% | 0.20% | -41.9% |
| Q2 2019 | $63,578,000 | +23.4% | 28,471,000 | 0.0% | 0.35% | +9.6% |
| Q1 2019 | $51,528,000 | – | 28,471,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |